nejm tirzepatide 📢 New in NEJM: 💉 vs. Semaglutide 💉 for obesity (no diabetes) 🧪 72-week RCT highlights: ⚖️ Weight loss: −20.2% vs. −13.7% 📏 Waist ↓: 18.4 cm vs. 13.0 cm 🎯 More patients hit ≥25% loss… Weight Regain after Stopping Obesity

Conclusions While GLP-1 receptor agonists do not appear to significantly increase overall surgical risks, their effects on tissue healing and bruising warrant further investigation

However, it is still recommended that they consider taking L-Carnitine supplements to ensure sufficient levels of the amino acid in their bodies

That might include consultations, GLP 1 prescriptions, lab work, and regular check ins with the care team

While human data are still limited, this mitochondrial-derived peptide highlights a novel link between cellular energy sensing and systemic metabolic health, with potential relevance for insulin resistance and diabetes-related conditions

telehealth platforms provide safe, legal access at comparable or lower prices than international purchasing without the associated risks